Session » Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster I: Clinical Aspects and Assessments

Date: Sunday, November 8, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 689

Are Individual or Country Level Socio-Economic Determinants Related to Disease Activity and Self-Reported Physical Function in Patients with Spondyloarthritis – Results from Multi-National Cross-Sectional Study Comospa

9:00AM-11:00AM: Abstract Number: 661

ASDAS Can be Reliably Calculated When Only the Patient’s Overall Basdai Score Is Available, but Not the Score(S) of Its Individual Component(S)

9:00AM-11:00AM: Abstract Number: 650

ASDAS-Based Remission Was Less Frequent Than Basdai-Based Remission, and Both Were Related to CRP and Smoking in Early Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 669

Assessment of Spinal Mobility in Axial Spondyloarthritis: First Validation Steps of a New Electronic Quantification Tool

9:00AM-11:00AM: Abstract Number: 692

Association Between Improvement in Enthesopathy and Quality of Life: Results from a Phase 3 T in Psoriatic Arthritis Patients

9:00AM-11:00AM: Abstract Number: 654

Associations Between Skin Outcomes By Body Area Affected and Health-Related Quality of Life in Patients with Psoriatic Arthritis Treated with Certolizumab Pegol

9:00AM-11:00AM: Abstract Number: 710

Baseline Characteristics of Early, Delayed, and Non-Responders in a Non-Radiographic Axial Spondyloarthritis Study

9:00AM-11:00AM: Abstract Number: 714

Baseline MRI and CRP As Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis (nr-axSpA)

9:00AM-11:00AM: Abstract Number: 662

Can the New Contest Questionnaire Identify Psoriatic Arthritis in a Primary Care Population?

9:00AM-11:00AM: Abstract Number: 707

Change of Enthesial Involvement Under Treatment Was Independent from the Therapeutic Strategy in Patients with Axial Spondyloarthritis within the Scqm Cohort

9:00AM-11:00AM: Abstract Number: 673

Characterization of Psoriatic Arthritis [Psa] in a Large, Integrated Health Plan: Demographics, Referral Patterns and Care Management

9:00AM-11:00AM: Abstract Number: 713

Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 104-Week Treatment Results

9:00AM-11:00AM: Abstract Number: 693

Clinical and Imaging Features of Reactive Arthritis in Guatemala City

9:00AM-11:00AM: Abstract Number: 678

Clinical Characteristics and Disease Activity in Psoriatic Arthritis Patients with Dactylitis or Enthesitis: Results from Corrona Registry

9:00AM-11:00AM: Abstract Number: 674

Clinical Characteristics of Japanese Patients with Reactive Arthritis Induced By Intravesical BCG Therapy for Bladder Cancer: A 19 Years Two-Center Retrospective Study

9:00AM-11:00AM: Abstract Number: 688

Clinical Improvements in Psoriasis and Psoriatic Arthritis with Surgical Weight Loss

9:00AM-11:00AM: Abstract Number: 653

Clinical Responses and Improvements in Patient-Reported Outcomes Are Associated with Increased Productivity in the Workplace and at Home in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol

9:00AM-11:00AM: Abstract Number: 667

Comparison of Patient and Provider Assessments of Response to Therapy for Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 660

Comparison of the Four Validated Psoriatic Arthritis Screening Tools in Diagnosing Psoriatic Arthritis in Patients with Psoriasis [Compaq Study]

9:00AM-11:00AM: Abstract Number: 665

Construct Validity of Disease Activity for Psoriatic Arthritis Composite Index and Tentative Cut-Off Values in a Cohort of Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 656

Convergent Construct Validity of PsAID12 in a Psoriatic Arthritis Cohort at Baseline

9:00AM-11:00AM: Abstract Number: 696

Current and Past Smoking Are Associated with Functional Impairement and Increased Disease Activity in Axial Spondyloarthritis: Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 708

Development of an Activity Disease Score in Patients with Uveitis

9:00AM-11:00AM: Abstract Number: 671

Discrepancy Between Patients and Physicians Acceptable Symptomatic States in Axial Spondyloarthritis: Findings from the RAPID-AxSpA Study

9:00AM-11:00AM: Abstract Number: 666

Disease Activity Indices and Body Mass Index: Cross-Sectional Analysis of a Large Psoriatic Arthritis Cohort

9:00AM-11:00AM: Abstract Number: 686

Does an Educational Leaflet Improve Attendance for Screening for Psoriatic Arthritis?

9:00AM-11:00AM: Abstract Number: 659

Does the Inclusion of Extra-Articular Manifestations Improve Validity of the Self-Administered Comorbidity Questionnaire Modified for Spondyloarthritis (SpA-SCQ)? Results from ASAS-Comospa

9:00AM-11:00AM: Abstract Number: 684

Evaluation of Patient Acceptable Symptom State in Patients with Axial Spondylarthritis; Similar Thresholds for Radiographic and Non-Radiographic Subgroups

9:00AM-11:00AM: Abstract Number: 670

Evaluation of the Predictive Value of Non-Specific Musculoskeletal Symptoms in Preclinical Phases of Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 712

Factors Associated with Anti-TNF Treatment in a Longitudinally Followed Ankylosing Spondylitis (AS) Cohort

9:00AM-11:00AM: Abstract Number: 711

Gender Specific Differences in Ankylosing Spondylitis at Treatment Initiation in Patients Treated with Infliximab or Golimumab

9:00AM-11:00AM: Abstract Number: 658

Health Related Quality of Life in Psoriatic Arthritis from the Perspective of People Living with the Condition

9:00AM-11:00AM: Abstract Number: 697

Identification Methods for Axial Spondyloarthritis in American Veterans

9:00AM-11:00AM: Abstract Number: 681

Impact of Disease Duration on Patient Reported and Clinical Outcomes in Patients with Ankylosing Spondylitis Treated with Anti-TNF: An Analysis from a Prospective, Observational Registry

9:00AM-11:00AM: Abstract Number: 699

Improving Ankylosing Spondylitis Specific Outcomes at 6 Months Utilising a Novel Self-Management Education Program

9:00AM-11:00AM: Abstract Number: 695

Is a Geriatric Rheumatology Sub-Group Worth Distinguishing? Disease Characteristics of a Geriatric Psoriatic Arthritis (Gero PsA) Subgroup Compared with Those of below 45 Years of Age

9:00AM-11:00AM: Abstract Number: 704

Is Axial Involvement Underestimated in Patients with Psoriatic Arthritis? Data from the Bepas Cohort

9:00AM-11:00AM: Abstract Number: 698

Is It Possible to Identify Psoriasis Patients Who Will Develop Axial Disease? Real Life Data from Psart (Psoriatic Arthritis Registry of Turkey)

9:00AM-11:00AM: Abstract Number: 702

Is Skin Disease More Important to Patients or Physicians in the Assessment of Disease Activity in Psoriatic Arthritis?

9:00AM-11:00AM: Abstract Number: 701

Is Skin Disease More Important to Women or Men in the Assessment of Disease Activity in Psoriatic Arthritis?

9:00AM-11:00AM: Abstract Number: 703

Isotretinoin-Induced Spondilartropathy-Related Symptoms: A Prospective Study

9:00AM-11:00AM: Abstract Number: 663

Mases Correlates Linearly with Disease Activity and Patient Related Outcomes in Patients with Axial Spondyloarthritis within the Scqm Cohort

9:00AM-11:00AM: Abstract Number: 649

Measures of Health-Related Quality of Life in Psoriatic Arthritis: Are They Sensitive to Both Joint and Skin Aspects?

9:00AM-11:00AM: Abstract Number: 682

Misalignment Between Physician and Patient Satisfaction with Current Psoriatic Arthritis Treatment

9:00AM-11:00AM: Abstract Number: 687

Mucosal Dysregulation in First-Degree Relatives of Ankylosing Spondylitis Patients

9:00AM-11:00AM: Abstract Number: 668

Pasdas, Cpdai and MDA Evolution in the First 6 Months after Diagnosis of Early Psoriatic Arthritis Patients: Results of the Depar Study

9:00AM-11:00AM: Abstract Number: 664

Patient Reported Outcomes and Assessment of the Quality of Life in a Cohort of Patients Affected By Enteropathic Spondyloarthritis: Definitive Results of a Monocentric Prospective Observational Study at One Year

9:00AM-11:00AM: Abstract Number: 679

Patients with Psoriatic Arthritis and Oligoarthritic Subtype Report Higher Disease Burden Than Patients with a Polyarthritic Pattern – Data from the German Collaborative Arthritis Centres

9:00AM-11:00AM: Abstract Number: 700

Problems of Untranslatability: Example of Turkish Version of Basdai

9:00AM-11:00AM: Abstract Number: 709

Progression of Patients with Non-Radiographic Axial Spondyloarthritis to Ankylosing Spondylitis: A Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 694

Quality of Life in Patients with Active Peripheral Spa Is Similarly Impaired As in Other Rheumatic Diseases and Influenced By Disease Activity but Not Disease Duration

9:00AM-11:00AM: Abstract Number: 655

Rasch Analysis of the Hospital Anxiety and Depression Scale in Psoriatic Arthritis: Results from the Presta Study.

9:00AM-11:00AM: Abstract Number: 683

Referral Strategies for the Early Diagnosis of Axial Spondyloarthritis- a Systematic Review

9:00AM-11:00AM: Abstract Number: 657

Routine Assessment of Patient Index Data 3 Score (RAPID3) and Psoriasis Quality of Life (PQoL-12) Assess Different Domains in Psoriasis (PsO) and Psoriatic Arthritis (PsA) Patients

9:00AM-11:00AM: Abstract Number: 685

Sacroiliitis Misdiagnosed As Spondyloarthritis: Clinical Analysis of 581 Cases

9:00AM-11:00AM: Abstract Number: 677

Satisfaction in Psoriatic Arthritis Patients Despite Active Joint Disease

9:00AM-11:00AM: Abstract Number: 705

Sex Differences in Psoriatic Arthritis: Evaluation of a Real-Life Cohort of 2,118 Italian Patients Treated with Methotrexate

9:00AM-11:00AM: Abstract Number: 691

Standards for the Classification of Non-Radiographic Axial Spondyloarthritis: A European Real World Study

9:00AM-11:00AM: Abstract Number: 690

The Impact of Ankylosing Spondylitis in Turkey on Productivity at Work Outside Home and within the Household

9:00AM-11:00AM: Abstract Number: 652

The Performance of Different Classification Criteria Sets for Spondyloarthritis in the Worldwide ASAS-Comospa Study

9:00AM-11:00AM: Abstract Number: 651

The Prediction of Long-Term Minimal Disease Activity and Its Benefits in Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 706

Undifferentiated Spondylarthritis May More Frequent in Japanese

9:00AM-11:00AM: Abstract Number: 672

Validity of Ankylosing Spondylitis Diagnoses in the Health Improvement Network

9:00AM-11:00AM: Abstract Number: 680

Variability over Time in Patient-Reported Outcome Measures in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 675

Vitamin D Deficiency in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis. Results of the CARMA Study

9:00AM-11:00AM: Abstract Number: 676

What Proportion of Patients with Psa Fail to Achieve MDA Based on Patient Reported Outcomes? an Analysis from a Prospective, Observational Registry

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].